Agar culture media manufacturing · Illinois

Novartis Gene Therapies Deerfield (Corporate)

Deerfield, IL · ~71 workers · 2 years of OSHA Injury Tracking Application data.

C
Average Safety Record
0.0
Avg TCR
3.3
Industry avg
0
Fatalities
Subscribe to safety-record updates (RSS)

The verdict

Novartis Gene Therapies Deerfield (Corporate) runs at 0% of its industry's injury rate - about level with the typical Agar culture media manufacturing workplace, earning a grade C.

Novartis Gene Therapies Deerfield (Corporate): 0.0 TCR = 0% of Agar culture media manufacturing BLS 3.3 · 2y Form 300A (see methodology below)

Novartis Gene Therapies Deerfield (Corporate) safety composite

Novartis Gene Therapies Deerfield (Corporate) scores strongest on total case rate (tcr) (safer than 100% of same-industry peers) and weakest on fatalities (safer than 50%), blended into one 0-100 breakdown against same-industry peers. A missing measure drops out and redistributes its weight rather than deflating the score. This is a per-dimension breakdown, distinct from the single letter grade above it (which weights TCR alone against the BLS industry benchmark).

B

82/100

Percentile-weighted across 3 of 3 measures

Total Case Rate (TCR)
A 0 per 100 workers

Safer than 100% of industry peers

DART rate
B 0 per 100 workers

Safer than 83% of industry peers

Fatalities
D 0

Safer than 50% of industry peers

Benchmarked live against every credibly-rated employer in the same NAICS industry code in the current OSHA extract (a segment must have at least 8 rated peers to benchmark). Not a legal or compliance determination; PlainSafetyScore's own weighting (TCR 40%, DART 35%, fatalities 25%).

Novartis Gene Therapies Deerfield (Corporate) held a steady TCR band

Novartis Gene Therapies Deerfield (Corporate)'s TCR held near 0.0 from 0.0 in 2020 to 0.0 in 2021. Peak filing year was 2020 at 0.0 TCR.

2020=0.0 · 2021=0.0

OSHA ITA Form 300A scorecard

Establishment book 325414 · Deerfield, IL AT/BELOW-IND · SMALL

Grade C · TCR 0.0 · 0% of ind

  • DART 0.0 DART
  • RANK #0/7
  • PHOTO Takeda: Bannockburn
  • BOOK 2y book
  • INJ 0 inj
  • SIZE ~71 FTE

Nearest TCR peer: Takeda: Bannockburn (0.0 TCR gap)

Read with this employer → · Industry book → · Illinois employers → · Look up another →

Novartis Gene Therapies Deerfield (Corporate) in the TCR neighbourhood

Average Total Case Rate among this establishment and nearest same-industry peers

TCR

What this shows Novartis Gene Therapies Deerfield (Corporate) averages 0.0 TCR (0% of the Agar culture media manufacturing BLS benchmark).

Source U.S. Department of Labor, OSHA Injury Tracking Application (Form 300A) As of 2026-08-25

Novartis Gene Therapies Deerfield (Corporate) TCR series: 2020=0 · 2021=0 · BLS 3.3

Where Novartis Gene Therapies Deerfield (Corporate) falls in its industry

234 Agar culture media manufacturi establishments

Safer than 100% of graded establishments in this industry, whose median TCR is 1.2.

More dangerous than peersSafer than peers

Narrower to Illinois alone (the establishments it most directly competes with for workers and contracts): ranked #0 safest of 7 Agar culture media manufacturi employers in Illinois.

Novartis Gene Therapies Deerfield (Corporate) (71 employees, TCR 0.0) among 29 same-industry peers, split at the industry median of 198 employees and a TCR of 1.2 2×2 strategic matrix plotting 30 entities by Average employees (X) and Total Case Rate (Y), with a crosshair dividing the plot into four quadrants. Larger & higher-riskSmaller & higher-riskLarger & saferSmaller & safer than peers 05001,0001,5002,000 0246 Average employees Total Case Rate Novartis Gene Therapies Deerfield (Corporate)
Novartis Gene Therapies Deerfield (Corporate) (71 employees, TCR 0.0) among 29 same-industry peers, split at the industry median of 198 employees and a TCR of 1.2

Novartis Gene Therapies Deerfield (Corporate) has fewer employees than the Agar culture media manufacturing median and a lower injury rate than the industry's median TCR of 1.2. Workforce size and injury rate do not always move together within the same industry -- some of its smaller peers run higher rates than its larger ones, and vice versa.

Year-by-Year Safety Data

Year TCR DART Injuries Illnesses Fatalities
2021 0.0 0.0 0 0 0
2020 0.0 0.0 0 0 0

OSHA ITA peer cross-reference

Establishment peer ledger

325414 · IL · Deerfield

234 Agar culture media manufacturing employers nationwide with a credible TCR · 22,804 rated employers in Illinois with headcount on file · 49 employers in Deerfield, IL · 4 cross-state NAT-TCR peers · 4 cross-state NAT-SIZE peers. Closest matches by relationship code are listed below.

Rel Establishment Metric
NAICS-TCR Takeda: Bannockburn 0.0 TCR
NAICS-TCR Biogen - Weston 0.1 TCR
NAICS-TCR Denali Therapeutics 0.1 TCR
NAICS-TCR Shire: 95 Hayden 0.1 TCR
STATE-SIZE Dwight, IL 71 FTE
STATE-SIZE 6697_16861 71 FTE
STATE-SIZE Menold Construction, Inc 71 FTE
STATE-SIZE Contegra Enterprises 71 FTE
CITY-NEAR Takeda Pharmaceuticals America, Inc. 1,904 FTE
CITY-NEAR Deerfield IL 1,427 FTE
CITY-NEAR Deerfield, IL - Corp Staff 1,400 FTE
CITY-NEAR Deerfield, IL -Medical Products 1,374 FTE
NAT-TCR Gap Inc. - Corporate 0.0 TCR
NAT-TCR Atlanta - Phipps 0.0 TCR
NAT-TCR Hampton Inn & Suites 0.0 TCR
NAT-TCR Meijer 208 0.0 TCR
NAT-SIZE Ii-Vi Ms 71 FTE
NAT-SIZE Interiors Jessup - Cleveland Construction 71 FTE
NAT-SIZE Interstate Mechanical Corp 71 FTE
NAT-SIZE STA-Little Elm (TEX-750) 71 FTE

Rel codes: NAICS-TCR · STATE-SIZE · CITY-NEAR · NAT-TCR/NAT-SIZE cross-state. Read with this employer →

Data Source: OSHA Injury Tracking Application (ITA), mandatory establishment-level injury/illness reports. Grades compare employer Total Case Rate (TCR) to BLS IIF industry benchmarks. Data covers years reported by this establishment: 2021, 2020. This is publicly available government data - not a legal determination of workplace conditions.
Data sourced from official public datasets. See our methodology for details.